Antithrombotic Therapy for VTE Disease
Authors:
- Scott M. StevensSSScott M. Stevens
- Scott C. WollerSWScott C. Woller
- Lisa Baumann KreuzigerLKLisa Baumann Kreuziger
- Frederikus A. KlokFKFrederikus A. Klok
- Christopher S. KingCKChristopher S. King
- Janine R.E. VintchJVJanine R.E. Vintch
- Philip S. WellsPWPhilip S. Wells
- Suman WasanSWSuman Wasan
- Lisa K. MooresLMLisa K. Moores
Top Cited Papers
Open Access
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Anticoagulation in chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysisThrombosis Research, 2023
- Risk stratification of acute pulmonary embolismJournal of Thrombosis and Haemostasis, 2023
- American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adultsJournal of the American Geriatrics Society, 2023
- Executive SummaryChest, 2021
- Antithrombotic Therapy for VTE DiseaseChest, 2021
- Therapy for Pulmonary Arterial Hypertension in AdultsChest, 2019
- Treatment of Superficial Vein Thrombosis: A Systematic Review and Meta-AnalysisThrombosis and Haemostasis, 2019
- Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTHJournal of Thrombosis and Haemostasis, 2016
- Update of Antithrombotic GuidelinesChest, 2016
- Antithrombotic Therapy for VTE DiseaseChest, 2016